BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 26062902)

  • 1. The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases.
    Tabarkiewicz J; Pogoda K; Karczmarczyk A; Pozarowski P; Giannopoulos K
    Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):435-49. PubMed ID: 26062902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis.
    Astry B; Venkatesha SH; Moudgil KD
    Cytokine; 2015 Jul; 74(1):54-61. PubMed ID: 25595306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.
    Yamagata T; Skepner J; Yang J
    Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):405-14. PubMed ID: 26358867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cellular and molecular view of T helper 17 cell plasticity in autoimmunity.
    Stadhouders R; Lubberts E; Hendriks RW
    J Autoimmun; 2018 Feb; 87():1-15. PubMed ID: 29275836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders.
    Kamali AN; Noorbakhsh SM; Hamedifar H; Jadidi-Niaragh F; Yazdani R; Bautista JM; Azizi G
    Mol Immunol; 2019 Jan; 105():107-115. PubMed ID: 30502718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease.
    Afzali B; Lombardi G; Lechler RI; Lord GM
    Clin Exp Immunol; 2007 Apr; 148(1):32-46. PubMed ID: 17328715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th17 cells in inflammation and autoimmunity.
    Singh RP; Hasan S; Sharma S; Nagra S; Yamaguchi DT; Wong DT; Hahn BH; Hossain A
    Autoimmun Rev; 2014 Dec; 13(12):1174-81. PubMed ID: 25151974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune state of Th1, Th2 and Th17 subpopulation in experimental autoimmune myocarditis].
    Han LN; Li TL; Zhang YJ; Yang TS; Ding Y; Guo SL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):751-6. PubMed ID: 22332535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionally distinct IFN-γ
    Chen YH; Eskandarpour M; Gondrand A; Zhang X; Gu R; Galatowicz G; Lightman SL; Calder VL
    Eur J Immunol; 2020 Dec; 50(12):1941-1951. PubMed ID: 32652562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis.
    Wang X; Zheng XY; Ma C; Wang XK; Wu J; Adem A; Zhu J; Zhang HL
    Scand J Immunol; 2014 Sep; 80(3):180-90. PubMed ID: 24910360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th1, Th2, and Th17 cytokines in systemic lupus erythematosus.
    Muhammad Yusoff F; Wong KK; Mohd Redzwan N
    Autoimmunity; 2020 Feb; 53(1):8-20. PubMed ID: 31771364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-17: a new actor in IFN-driven systemic autoimmune diseases.
    Ambrosi A; Espinosa A; Wahren-Herlenius M
    Eur J Immunol; 2012 Sep; 42(9):2274-84. PubMed ID: 22949326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis.
    Ohshima M; Yamahara K; Ishikane S; Harada K; Tsuda H; Otani K; Taguchi A; Miyazato M; Katsuragi S; Yoshimatsu J; Kodama M; Kangawa K; Ikeda T
    J Mol Cell Cardiol; 2012 Sep; 53(3):420-8. PubMed ID: 22796574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T helper 17 cells in autoimmune liver diseases.
    Abe M; Hiasa Y; Onji M
    Clin Dev Immunol; 2013; 2013():607073. PubMed ID: 24223606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.
    Roeleveld DM; van Nieuwenhuijze AE; van den Berg WB; Koenders MI
    BioDrugs; 2013 Oct; 27(5):439-52. PubMed ID: 23620106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of autoimmune diseases by interleukin (IL)-17 producing regulatory T helper (Th17) cells.
    Singh B; Schwartz JA; Sandrock C; Bellemore SM; Nikoopour E
    Indian J Med Res; 2013 Nov; 138(5):591-4. PubMed ID: 24434314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17 and Th17 cells in systemic sclerosis: a comprehensive review.
    Bălănescu P; Bălănescu E; Bălănescu A
    Rom J Intern Med; 2017 Dec; 55(4):198-204. PubMed ID: 28704201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th17 cells in primary Sjögren's syndrome: Pathogenicity and plasticity.
    Verstappen GM; Corneth OBJ; Bootsma H; Kroese FGM
    J Autoimmun; 2018 Feb; 87():16-25. PubMed ID: 29191572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose interleukin-2 therapy: a driver of an imbalance between immune tolerance and autoimmunity.
    Kosmaczewska A
    Int J Mol Sci; 2014 Oct; 15(10):18574-92. PubMed ID: 25322151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.